Moderna says its COVID-19 shot 93% effective six months after second dose

Published by

By Michael Erman (Reuters) -Moderna Inc said on Thursday its COVID-19 shot was about 93% effective through six months after the second dose, showing hardly any change from the 94% efficacy reported in its original clinical trial. That compares favorably to data from Pfizer Inc and BioNTech SE last week in which they said their vaccine’s efficacy waned around 6% every two months, declining to around 84% six months after the second shot. Both the Moderna and Pfizer-BioNTech vaccines are based on messenger RNA (mRNA) technology. “Our COVID-19 vaccine is showing durable efficacy of 93% through six…

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *